期刊文献+

围手术期输血与肝癌复发 被引量:3

Perioperative blood transfusion and hepatic cancer recurrence
下载PDF
导出
摘要 输血作为临床治疗的重要手段之一,是影响肝癌患者术后复发的重要因素,其影响机制可能是输血造成机体免疫功能抑制,阻碍机体对肿瘤的免疫应答,促进肿瘤复发,术者应严格掌握输血指征,以减少输血对肝癌患者术后复发的不良影响。
作者 王鑫 杨广顺
出处 《第二军医大学学报》 CAS CSCD 北大核心 2005年第10期1184-1185,共2页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30170912)
  • 相关文献

参考文献17

  • 1Kwon AH, Matsui Y, Kamiyama Y.Perioperative blood transfusion in hepatocellular carcinomas[J].Cancer,2001,91(14):771-778. 被引量:1
  • 2Sibrowski W, Wegner W, Kuhnl P.Immunomodulatory activity of different blood products on the mitogen-induced human lymphocyte transformation[J]. Transfus Med,1992,2(3):215-221. 被引量:1
  • 3Inuzuka S, Koga S, Nishikido M,et al. Donor-specific blood transfusion prolongs cardiac allograft survival in rats by low nitric oxide production and elevated serum levels of prostaglandin E2[J]. Immunol Lett,2002,83(2):119-124. 被引量:1
  • 4Wong W, Wood KJ.Transplantation tolerance by donor MHC gene transfer[J].Curr Gene Ther,1994,4(3):329-336. 被引量:1
  • 5Innerhofer P, Tilz G, Fuchs D,et al. Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. Ⅱ. Activation of T cells, macrophages, and cell-mediated lympholysis[J]. Transfusion, 2000,40(7):821-827. 被引量:1
  • 6Asahara T,Katayama K,Itamoto T,et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma[J]. World J Surg,1999,23(7):676-680. 被引量:1
  • 7Kubo S,Kinoshita H,Hirohashi K, et al. Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation[J]. Hepatogastroenterology, 1999,46(30):3212-3215. 被引量:1
  • 8Makino Y, Yamanoi A, Kimoto T,et al. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma[J]. Am J Gastroenterol, 2000,95(5):1294-1300. 被引量:1
  • 9Kim WW, Lee KW, Choi SH, et al. Risk factors of morbidity and mortality following surgical resection for hepatocellular carcinoma[J].Korean J Hepatology, 2004,10(1):51-61. 被引量:1
  • 10Yamamoto J, Kosuge T, Takayama T,et al.Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy [J].Surgery,1994,115(3):303-309. 被引量:1

同被引文献24

  • 1李琦,唐琦峰,钱燕宁,季晓辉,王忠云,田家骏.围手术期异体输血对胃癌病人T细胞亚群的影响[J].东南大学学报(医学版),2004,23(5):304-307. 被引量:3
  • 2唐琦峰,钱燕宁,季晓辉.输血与免疫抑制[J].中国综合临床,2004,20(12):1149-1151. 被引量:6
  • 3贾文焯,韦军民.输血对免疫系统的影响[J].中国实用外科杂志,2007,27(2):171-173. 被引量:11
  • 4杨甲梅,隋承军.半肝血流完全阻断下无血肝切除术的临床应用:附14例报告[J].中华肝胆外科杂志,2007,13(5):297-299. 被引量:19
  • 5Eldftherios CV. Possible mechanisms of allogeneie blood transfusion-associated postoperative infection. Transfusion Med Rev, 2002,16(2) :144-160. 被引量:1
  • 6Tomas TT, Efika MC, Vicki B, et al. Perioperative blood transfusion is predictive of poststemotomy surgical site infection: Marker for morbidity or true immunosuppressant? Clin Infec Dis,2004,38 (15) :1378-1382. 被引量:1
  • 7Li A, Pan Z, Zhou W, et al. Superior approach for the exclusion of hepatic veins in major liver resection: a safe and easy technique[J]. Surg Today, 2009, 39(3) : 269 - 273. 被引量:1
  • 8Gurusamy KS, Sheth H, Kumar Y, et al. WITHDRAWN: Methods of vascular occlusion for elective liver resections [ J ].Cochrane Database Syst Rev, 2009 , 21 ( 1 ) : CD006409. 被引量:1
  • 9Lesurtel M, Selzner M, Petrewsky H, et al. How should transection of the liver be performed ? : a prospactive randomized study in 100 consccutive patients: comparing four different transection strategies [J]. Ann Surg, 2005, 242(6) : 818 -822. 被引量:1
  • 10Tsuruma T, Sahara H, fonolipids deduced from urchin reduces hepatic [ J ] . Transplant Proc , Takenouchi M, et al. Synthetic sul- sulfonoquinovosyl diacylglycernls of sea ischemiareperfusion injury in rats 2004, 36(7) : 1965 -1969. 被引量:1

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部